FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

385060002: comprimé oral à libération prolongée (forme pharmaceutique)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3636013018 Prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636014012 Prolonged-release oral tablet (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636019019 Extended-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
50021051000188114 comprimé oral à libération prolongée fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
616331000241117 comprimé oral à libération prolongée (forme pharmaceutique) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


3 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release oral tablet est un(e) (attribut) comprimé false Inferred relationship Some
Prolonged-release oral tablet est un(e) (attribut) Oral tablet false Inferred relationship Some
Prolonged-release oral tablet Has dose form intended site (attribute) Oral true Inferred relationship Some
Prolonged-release oral tablet est un(e) (attribut) comprimé oral à libération modifiée true Inferred relationship Some
Prolonged-release oral tablet Has dose form administration method (attribute) Swallow (administration method) true Inferred relationship Some
Prolonged-release oral tablet Has dose form transformation (attribute) No transformation true Inferred relationship Some
Prolonged-release oral tablet Has dose form release characteristic (attribute) Prolonged-release (release characteristic) true Inferred relationship Some
Prolonged-release oral tablet Has basic dose form (attribute) comprimé true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Niacin 1 g and simvastatin 20 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Niacin 750 mg and simvastatin 20 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Guanfacine (as guanfacine hydrochloride) 4 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Amoxicillin anhydrous (as amoxicillin) 775 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) False Prolonged-release oral tablet Inferred relationship Some
Nevirapine 50 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Metoprolol tartrate (as metoprolol succinate) 25 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Metoprolol tartrate (as metoprolol succinate) 50 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely metoprolol tartrate (as metoprolol succinate) 100 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely metoprolol tartrate (as metoprolol succinate) 200 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely fostemsavir 600 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely ferrous sulfate 325 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely upadacitinib 15 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely cefaclor 375 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Ranolazine 375 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely paroxetine (as paroxetine hydrochloride) 25 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Aminophylline hydrate 225 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely aminophylline hydrate 350 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Biperiden hydrochloride 4 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely tramadol hydrochloride 50 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Venlafaxine (as venlafaxine hydrochloride) 37.5 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Venlafaxine (as venlafaxine hydrochloride) 225 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Budesonide 9 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Quetiapine (as quetiapine fumarate) 50 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Quetiapine (as quetiapine fumarate) 150 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Clarithromycin (as clarithromycin citrate) 500 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely tofacitinib (as tofacitinib citrate) 11 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely tapentadol (as tapentadol hydrochloride) 50 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely tapentadol (as tapentadol hydrochloride) 150 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Tapentadol (as tapentadol hydrochloride) 100 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely tapentadol (as tapentadol hydrochloride) 250 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely tapentadol (as tapentadol hydrochloride) 200 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely tamsulosin hydrochloride 400 microgram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely ranolazine 750 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely ranolazine 500 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Tacrolimus 4 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely tacrolimus 1 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Tacrolimus 750 microgram prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely nevirapine 100 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely conjugated estrogen 625 microgram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely conjugated estrogen 1.25 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely mesalazine 1 gram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely paroxetine (as paroxetine hydrochloride) 12.5 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely paroxetine (as paroxetine hydrochloride) 37.5 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 3.15 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.05 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 2.1 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 520 microgram prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 260 microgram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Acetaminophen 1 g prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Isosorbide mononitrate 30 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely aciclovir 1.2 gram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Niacin 375 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely finasteride 5 milligram and tamsulosin hydrochloride 400 microgram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Alfuzosin hydrochloride 10 mg and dutasteride 500 microgram prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely zolpidem tartrate 12.5 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Piribedil 50 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 1.57 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Pramipexole (as pramipexole dihydrochloride) 2.62 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely carvedilol phosphate 10 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely carvedilol phosphate 20 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely metoprolol tartrate (as metoprolol succinate) 12.5 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Ambroxol acefyllinate 100 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely gliclazide 60 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely amoxicillin 775 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Aceclofenac 200 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely valproate sodium 133 milligram and valproic acid 58 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Valproate sodium 333 mg and valproic acid 145 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely valproate sodium 200 milligram and valproic acid 87 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely lamotrigine 25 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely lamotrigine 50 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Lamotrigine 200 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Lamotrigine 300 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Lamotrigine 100 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Lamotrigine 250 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Alprazolam 1 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Alprazolam 500 microgram prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Amisulpride 100 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely amisulpride 400 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely amisulpride 200 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Prazosin (as prazosin hydrochloride) 5 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely melatonin 2 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
comprimé oral pelliculé à libération prolongée est un(e) (attribut) True Prolonged-release oral tablet Inferred relationship Some
Gastro-resistant and prolonged-release oral tablet est un(e) (attribut) True Prolonged-release oral tablet Inferred relationship Some
Paliperidone 3 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Quetiapine (as quetiapine fumarate) 300 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely nicotinic acid 250 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Paliperidone 6 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Quetiapine (as quetiapine fumarate) 200 mg prolonged-release oral tablet a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely zileuton 600 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) True Prolonged-release oral tablet Inferred relationship Some

Page 1 of 4 Next End


This concept is not in any reference sets

Back to Start